Hydrazided hyaluronan/cisplatin/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 276, 118810
Abstract
No abstract availableKeywords
Funding Information
- Shaanxi Province Natural Science Foundation
- Wu Jieping Medical Foundation (320.6750.2020-01-15, 320.6750.2021-16-11)
- Key Technology Research and Development Program of Shandong Province (2020GY-290, 2020SF-033)
- National Natural Science Foundation of China (52103185, 82073309)
This publication has 59 references indexed in Scilit:
- Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug DeliveryJournal of the American Chemical Society, 2014
- Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin deliveryCarbohydrate Polymers, 2013
- Liposomal paclitaxel formulationsJournal of Controlled Release, 2012
- Terminal deoxynucleotidyl transferase: The story of a misguided DNA polymeraseBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Preparation, characterization and chlorine stability of aromatic–cycloaliphatic polyamide thin film composite membranesJournal of Membrane Science, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Molecular Reaction Mechanisms of Combination Treatments of Low-Dose Cisplatin with Radiotherapy and Photodynamic TherapyJournal of Medicinal Chemistry, 2007
- Synthesis of Near-Infrared-Absorbing Nanoparticle-Assembled CapsulesChemistry of Materials, 2007
- Nanotechnology: Intelligent Design to Treat Complex DiseasePharmaceutical Research, 2006
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004